Bcl-2 blocks apoptotic signal of transforming growth factor-beta in human hepatoma cells
Abstract:
Transforming growth factor-beta (TGF-beta) has been shown to induce apoptosis on normal hepatocytes and hepatoma cells both in vitro and in vivo. However, how the TGF-beta induces apoptosis is still not clear. We examined the expression of anti-apoptosis proteins and sensitivity to TGF-beta in three well differentiated human hepatoma cell lines. Two TGF-beta sensitive cell lines Hep3B and HuH7 totally lacked Bcl-2. In contrast, the TGF-beta resistant HepG2 cells expressed a substantial amount of Bcl-2. All three cell lines expressed equal amounts of Bcl-X(L), Bcl-X(S) and Bax. Overexpression of Bcl-2 in Hep3B and HuH7 cells protected them from TGF-beta-induced apoptosis. TGF-beta treatment increased intracellular peroxide production and suppressed the expression of glutathione-S-transferase in the Hep3B cells, and these effects were partially suppressed by the overexpression of Bcl-2. These results suggest that Bcl-2 may protect cell from TGF-beta-F-induced apoptosis by interfering TGF-beta generated signals leading to induce reactive oxygen species production.
Insights
Bcl-2, an anti-apoptosis protein, protects hepatoma cells from transforming growth factor-beta (TGF-beta)-induced cell death. Its absence correlates with TGF-beta sensitivity, suggesting a key role in liver cancer progression.
Area of Science:
- Hepatology
- Molecular Biology
- Cancer Research
Background:
- Transforming growth factor-beta (TGF-beta) induces apoptosis in liver cells, but the underlying mechanisms remain unclear.
- Understanding the role of apoptosis regulators is crucial for targeting liver cancer.
Purpose of the Study:
- To investigate the role of Bcl-2 in mediating TGF-beta-induced apoptosis in human hepatoma cell lines.
- To explore the relationship between Bcl-2 expression levels and sensitivity to TGF-beta.
Main Methods:
- Analysis of Bcl-2 protein expression in three human hepatoma cell lines (Hep3B, HuH7, HepG2) with varying TGF-beta sensitivity.
- Overexpression of Bcl-2 in sensitive cell lines to assess its protective effects.
- Measurement of intracellular peroxide production and glutathione-S-transferase expression following TGF-beta treatment.
Main Results:
- TGF-beta-sensitive cell lines (Hep3B, HuH7) lacked Bcl-2, while TGF-beta-resistant HepG2 cells expressed substantial Bcl-2.
- Overexpression of Bcl-2 conferred resistance to TGF-beta-induced apoptosis in Hep3B and HuH7 cells.
- Bcl-2 overexpression partially mitigated TGF-beta-induced reactive oxygen species production and suppressed glutathione-S-transferase expression.
Conclusions:
- Bcl-2 plays a significant protective role against TGF-beta-induced apoptosis in hepatoma cells.
- TGF-beta may induce apoptosis partly through reactive oxygen species generation, a pathway modulated by Bcl-2.
- Targeting Bcl-2 or related pathways could be a therapeutic strategy for liver cancer.
More Related Videos
09:18Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Abnormal Proliferation
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
TGF - β Signaling Pathway
Cellular Injury V: Apoptosis and Autophagy
